Jiangsu Nanfang MedicalNet loss widened to 17.79 million yuan with revenue down 11.51%.

Nanwei Shares released its 2026 interim report, showing total operating revenue of 271 million yuan, down 11.51 percent year on year, and a net loss attributable to the parent company of 17.79 million yuan, with the loss widening by 4.82 million yuan compared with the same period last year. Net cash inflow from operating activities was 30.12 million yuan, down 14.42 percent year on year. The company's asset-liability ratio rose to 81.31 percent, gross margin was 10.35 percent, return on equity was negative 11.16 percent, and diluted earnings per share was negative 0.06 yuan. The number of shareholders was 11,700, and the top ten shareholders held 56.95 percent of the total share capital.
Jiangsu Nanfang MedicalNet loss widened to 17.79 million yuan with revenue down 11.51%.